Truncated protein of interleukin-1
US4762914A · kind A · utility
37Cited by
0References
3Claims
0Family size
Inventors
Key dates
| Filing date | Feb 11, 1985 |
| Grant date | Aug 9, 1988 |
| Priority date | — |
| Expiry date | Feb 11, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/141
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The subject invention concerns truncated human IL-1 cDNA sequences which encode biologically-active novel human IL-1 proteins. These truncated human IL-1 cDNA sequences can be obtained by genetic engineering procedures using a clone of human IL-1 cDNA, having the accession number NRRL B-15770, as a starting material. The truncated human IL-1 cDNA sequences of the subject invention are contained in specified plasmids whose constructions are described in detail. Biologically-active human IL-1 proteins are useful to induce the production of IL-2 by activated T-cells. They also act on B-cells and NK-cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.